Effect of dapagliflozin on coronary microcirculation in patients with ejection fraction preserved heart failure

9 May 2026 (08:30 - 09:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Zhen Hong Zhang

Second People's Hospital Of Foshan, Foshan (China)

6 More presentations in this session

Presentation thumbnail

Nutritional status and its impact on transthyretin cardiac amyloidosis: a prospective 1-year study

Mrs P. Lujan Garcia (Las Palmas de Gran Canaria, ES)

Abstract Slides

Presentation thumbnail

Phenotypic clusters and sacubitril/valsartan in heart failure with preserved ejection fraction: a PARAGON-HF substudy

Doctor W. Kim (Seoul, KR)

Abstract Slides

Presentation thumbnail

Identification of HFpEF using the H2FPEF score in consecutively admitted patients without a primary heart failure diagnosis

Doctor A. Komaromi (Budapest, HU)

Abstract Slides

Presentation thumbnail

Diagnostic evaluation and recognition of HFpEF in routine clinical practice: a multicentre retrospective study

Miss K. Buitenhuis (Rotterdam, NL)

Abstract Slides

Presentation thumbnail

Obesity and the risk of heart failure hospitalization and death in patients with heart failure and left ventricular ejection fraction >50% - results of 1 year follow-up of HF-POL study

Ms J. Resch (Lodz, PL)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - heart failure with HFpEF (2)

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET

You may be interested in

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Webinar

Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources